Forbion-backed biotech raises $138M to develop ALS drug
Nov 14, 2023 · Forbion-backed biotech raises $138M to develop ALS drug Three-year-old startup VectorY plans to use the Series A funding to advance a vectorized antibody for ALS into …
OFF
Forbion-backed Biotech Raises $138M To Develop ALS Drug
2 days from now
Nov 14, 2023 · Forbion-backed biotech raises $138M to develop ALS drug Three-year-old startup VectorY plans to use the Series A funding to advance a vectorized antibody for ALS into …
biopharmadive.com
OFF
VectorY Raises €129 Million ($138 Million) Series A Financing To ...
2 days from now
Nov 13, 2023 · Round co-led by EQT Life Sciences and Forbion. Series A financing will support clinical development of the lead program in Amyotrophic Lateral Sclerosis (ALS), and …
vectorytx.com
OFF
Forbion-Backed VectorY Therapeutics Raises $138M For ALS And ...
2 days from now
VectorY Therapeutics, a biotechnology company based in Amsterdam, Netherlands, has secured $138 million (129 million euros) in a Series A financing round. This significant investment will …
industryexaminer.com
OFF
Forbion-backed Biotech Raises $138M To Develop ALS Drug
2 days from now
Nov 14, 2023 · The Series A financing, announced Monday, was co-led by venture capital firm Forbion and European investor EQT Life Sciences, alongside new backers that included …
alphastox.com
OFF
Forbion-backed Biotech Raises $138M To Develop ALS Drug
2 days from now
Nov 14, 2023 · Netherlands-based biotechnology company VectorY Therapeutics has raised 129 million euros, or $138 million, to fund development of brain disease drugs.
platohealth.ai
OFF
VTX-002 (Venn Therapeutics) - Drug Targets, Indications, Patents
2 days from now
Nov 13, 2024 · Forbion-backed biotech raises $138M to develop ALS drug. ... alongside new backers that included Merck & Cos venture arm and the ALS Investment Fund.According to …
patsnap.com
OFF
Forbion Co-leads €129 Million Series A Financing Of VectorY, One …
2 days from now
Nov 13, 2023 · Round co-led by Forbion and EQT Life SciencesFinancing will support clinical development of VTx-002, a potentially disease-modifying therapy for Amyotrophic Lateral …
yahoo.com
OFF
Forbion Co-leads €129 Million Series A Financing Of VectorY, One …
2 days from now
Nov 13, 2023 · Forbion manages €3 billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development. Forbion’s current team consists of over 30 life …
forbion.com
OFF
VectoryTx - Company Profile - Tracxn
2 days from now
Oct 11, 2024 · Forbion-backed biotech raises $138M to develop ALS drugBioPharmaDive • Nov 14, 2023 • VectoryTx, EQT, Merck, ALS Investment Fund Amsterdam’s VectorY Therapeutics …
tracxn.com
OFF
Forbion Raises In Excess Of €2 Billion For Two New Funds
2 days from now
Oct 15, 2024 · Naarden, The Netherlands, October 15, 2024 – Forbion, a leading global life sciences venture capital firm with deep expertise in Europe, today announces that it has raised …
forbion.com
OFF
Forbion Follows String Of Startup Exits With $2.2B Fundraise
2 days from now
Oct 15, 2024 · Forbion Growth Opportunities III pulled in 1.2 billion euros, while Forbion Ventures VII secured 890 million euros. Both funds exceeded their original targets, bringing the firm’s …
biopharmadive.com
OFF
Forbion Announces First Close Of Its New BioEconomy Fund I: …
2 days from now
Jun 20, 2024 · Forbion manages €3 billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development. Forbion’s current team consists of over 30 life …
forbion.com
OFF
Forbion Announces First Close Of Its New BioEconomy Fund I: …
2 days from now
Jun 20, 2024 · Forbion, a leading European life sciences venture capital firm, announces the first close of its new fund strategy, Forbion BioEconomy Fund I at €75 million.Forbion BioEconomy …
yahoo.com
OFF
Ferrer Offers $122M Biobucks For Ex-US License To Verge ALS Drug
2 days from now
Mar 25, 2024 · Ferrer has signed off on over 112.5 million euros ($121.7 million) in combined upfront and potential development and commercial milestone payments for the ex-U.S. rights …
fiercebiotech.com
OFF
Forbion Co-leads $100 Million Series A Funding In Navigator …
2 days from now
Aug 27, 2024 · Forbion invests in innovative biotech companies, managing €3.2 billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development. In …
forbion.com
OFF
Forbion Leads £35 Million (c.$43 Million) Series A Financing In …
2 days from now
Oct 2, 2024 · Naarden, The Netherlands, 02 October, 2024 – Forbion, a leading global life sciences venture capital firm with deep expertise in Europe, today announces the successful …
forbion.com
OFF
Forbion-backed Biotech Progentos Debuts With $65M For MS Drug
2 days from now
May 20, 2024 · Forbion, a well-known backer of life sciences startups, is leading an investment round for a newly launched biotechnology company focused on diseases that affect nerve …
biopharmadive.com
FAQs about Forbion-backed biotech raises $138M to develop ALS drug Coupon?
Does forbion's Growth Opportunities Fund II lead a series a financing?
What happened to forbion Therapeutics?
Who is forbion?
How many companies will the forbion growth opportunities fund invest in?
What is forbion's strategy?
How many investments does forbion have?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
